Alexis Kazen

Ms. Alexis Kazen

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
AKAlexis Kazen
Alexis Kazen
LULaura Glass Umfleet
Laura Glass Umfleet
FAFatima Aboulalazm
Fatima Aboulalazm
ACAlexander D. Cohen
Alexander D. Cohen
STScott Terhune
Scott Terhune
JKJohn R. Kirby
John R. Kirby
Background/Objectives: The interplay between the gut microbiome (GMB) and neurovascular function in neurodegeneration is unclear. The goal of this proof-of-concept, cross-sectional study is to identify relationships between the GMB, neurovascular functioning, and cognition in amnestic mild cognitive impairment (aMCI), the prototypical prodromal symptomatic stage of Alzheimer’s disease (AD). Methods: Participants (n = 14 aMCI and 10 controls) provided fecal samples for GMB sequencing (16S and shotgun metagenomics), underwent MRI, and completed cognitive testing. Cerebral vascular reactivity (CVR), cerebral blood flow (CBF), and arterial transit time (ATT) were assessed. Statistical analyses evaluated the relationships between discriminatory taxa, cerebrovascular metrics, and cognition. Results: Sequencing revealed differentially abundant bacterial and viral taxa distinguishing aMCI from controls. Spearman correlations revealed that bacteria known to induce inflammation were negatively associated with CVR, CBF, and cognition, and positively associated with ATT. A reciprocal pattern emerged for the association of taxa with gut health. Conclusions: Our results provide preliminary evidence that pro-inflammatory gut bacterial and viral taxa are associated with neurovascular dysfunction and cognitive impairment in prodromal AD, highlighting their potential as candidate microbial biomarkers and targets for early intervention.

11 July 2025 in Journal of Experimental Biology
Verified
Journal Article
Closed access
AKAlexis Kazen
Alexis Kazen
JGJustin L. Grobe
Justin L. Grobe
JKJohn R. Kirby
John R. Kirby
The role of the gut microbiota in influencing physiological processes has become increasingly evident over the past several decades. One such process, thermogenesis, has become a topic of interest in recent years owing to the threat of climate change as well as the ongoing obesity epidemic. Here, we offer an overview of current knowledge regarding the contributions of the gut microbiota to thermogenesis in ecological and biomedical contexts. We first describe how the metabolic and behavioral changes associated with the gut microbiota can lead to changes in energy balance, allowing animals to adapt to environmental stressors. We then discuss how changes in the gut microbial community composition, such as through antibiotic use, can lead to dysfunctional thermoregulation and, ultimately, disease states. Finally, we consider how microbes can be exploited to improve energy balance and propose some future directions worthy of additional study.

1 September 2025 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
EWElizabeth C. Welsch
Elizabeth C. Welsch
MBMatthew R. Barron
Matthew R. Barron
KSKatelyn M. Storage
Katelyn M. Storage
AKAlexis Kazen
Alexis Kazen
FAFatima Aboulalazm
Fatima Aboulalazm
TKTammy Lyn Kindel
Tammy Lyn Kindel
We propose that the metabolic benefits of sleeve gastrectomy are initiated by decreased liver transcription of cyp8b1 and slc10a1. A notable downstream effect includes changes in systemic bile acid composition and circulation, including increased LCA. An altered gut microbiome after surgery includes increases in Ligilactobacillus that was shown to express a bile salt hydrolase, which could be a contributor to the post-sleeve gastrectomy gut microbiome changes.

1 June 2025 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
MHMatthew A. Hadiono
Matthew A. Hadiono
AKAlexis Kazen
Alexis Kazen
FAFatima Aboulalazm
Fatima Aboulalazm
CBColin M. L. Burnett
Colin M. L. Burnett
JRJohn J. Reho
John J. Reho
JKJohn R. Kirby
John R. Kirby
The gut microbial community represents a thermogenic biomass. The composition of the microbial community dictates energy expenditure of the microbial biomass and is altered by xenobiotics and bacterial metabolites. This study demonstrates that treatment with reutericyclin positively modulates anaerobic energy expenditure and may represent a novel therapeutic in the treatment of obesity.

24 December 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
AKAlexis Kazen
Alexis Kazen
LULaura Glass Umfleet
Laura Glass Umfleet
FAFatima A Aboulalazm
Fatima A Aboulalazm
ACAlexander D Cohen
Alexander D Cohen
STScott Terhune
Scott Terhune
JKJohn Kirby
John Kirby
Background: Gut dysbiosis and cerebrovascular disease have both been implicated in Alzheimer's disease (AD) progression and pathophysiology. However, the interplay between them is unclear. The goal of this study was to identify relationships between gut microbiota (GMB), cerebrovascular functioning, and cognition in patients diagnosed with amnestic mild cognitive impairment (aMCI) compared to cognitively unimpaired older adult controls. Methods: Participants ( N = 14 aMCI and 10 controls) provided fecal samples for 16S and shotgun metagenomics GMB sequencing, underwent an MRI, and completed neuropsychological tests. For MRI, cerebral vascular reactivity (CVR), cerebral blood flow (CBF) and arterial transit time (ATT) were assessed. Spearman rho correlational analysis was used to evaluate relationships between discriminatory microbial taxa, cerebrovascular metrics, and cognition. Results: Sequencing revealed differentially abundant bacterial and viral taxa distinguishing aMCI from controls. Spearman correlations revealed that bacteria known to induce inflammation were negatively associated with cognition and cerebrovascular function, whereas bacteria associated with a healthy gut microbiome had positive associations with cognitive and cerebrovascular function. For example, Alistipes indistinctus , which depletes intestinal urate levels was enriched in aMCI and had significant negative correlations with Trail Making Test‐B (TMT‐B; r s =‐.587) and category fluency (CF) scores (r s =‐.422), CVR (r s =‐.437), and CBF (r s =‐.546). Bilophila wadsworthia was negatively associated (trend‐level) with CVR and CBF, and significantly correlated with TMT‐B ( r s = ‐.499) and category fluency ( r s = ‐.503). The bile acid modifying bacterium, Turicibacter sp ., had a significant positive correlation with CBF (r s =.423). Finally, we found that several bacteriophages had significant correlations with cognitive and cerebrovascular measures, such as a B. wadsworthia phage that was enriched in aMCI and had significant negative correlations with TMT‐B (r s =‐.491), delayed recall (r s =‐.589), and CVR (r s =‐.474). Further, this phage contained an acyl‐coA synthetase capable of influencing central metabolism. Conclusions: Consistent with previous research, we found that persons with aMCI have an altered gut microbiome relative to controls. Further, we demonstrate through metagenomics sequencing that both bacterial and viral taxa are associated with cognitive and neurovascular functioning in aMCI. Knowledge about the relationships between the microbiota, cognition, and cerebrovascular function paves the way for future studies cross‐sectional and longitudinal studies.